Salkind Gene 4
4 · Mobiquity Technologies, Inc. · Filed Jul 29, 2024
Insider Transaction Report
Form 4
Salkind Gene
Director10% Owner
Transactions
- Award
Convertible Promissory Notes
2024-07-25+50,000→ 8,135,931 totalExercise: $0.50From: 2024-07-25→ Common Stock (100,000 underlying)
Footnotes (2)
- [F1]Not applicable.
- [F2]The derivative securities listed in Table II are derivative securities owned directly by Dr. Salkind and his wife and by a family trust.